UBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with overweight or obesity: A multicenter, randomized phase 2 trial. (linkinghub.elsevier.com)

Authors: Zhou Z … Yan H Journal: Cell Metabolism Published: 2026-10-07 DOI: https://doi.org/10.1016/j.cmet.2026.09.021